ACM
JAZZ icon

Aster Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Aster Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.4K Sell
140
-37
-21% -$6.47K 0.01% 570
2025
Q4 		$30.1K Sell
177
-155
-47% -$23.8K 0.01% 545
2025
Q3 		$43.8K Sell
332
-105
-24% -$12.6K 0.02% 522
2025
Q2 		$46.4K Sell
437
-10,936
-96% -$1.19M 0.01% 614
2025
Q1 		$1.63M Buy
+11,373
New +$1.48M 0.3% 79

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Aster Capital Management's JAZZ Position: Q1 2026 in Review

Aster Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 21% in Q1 2026, selling an estimated $6.47K and leaving 140 shares worth $17.4K. The position accounts for 0.01% of the portfolio, ranked #570.

Aster Capital Management first reported a position in JAZZ in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.63M in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Aster Capital Management held 140 shares of Jazz Pharmaceuticals worth $17.4K as of Q1 2026.
  • Aster Capital Management sold 37 Jazz Pharmaceuticals shares in Q1 2026, an estimated $6.47K.
  • Jazz Pharmaceuticals made up 0.01% of Aster Capital Management's portfolio in Q1 2026, its #570 holding.
  • Aster Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Aster Capital Management's Jazz Pharmaceuticals position peaked at $1.63M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.